Acciones Myovant Sciences Ltd.
Acciones
MYOV
BMG637AM1024
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Director/Board Member | 59 | 22/10/22 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.11% | 0 M€ | 0,00 % | - | |
0.08% | 0 M€ | 0,00 % | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,12 % | 43,84 mil M | |
+6,77 % | 41,68 mil M | |
+45,26 % | 41,25 mil M | |
-11,96 % | 27,04 mil M | |
+6,01 % | 25,53 mil M | |
-24,92 % | 18,18 mil M | |
-3,63 % | 12,29 mil M | |
+27,16 % | 12,29 mil M | |
+7,30 % | 11,15 mil M |